Introduction
Information and methods
General data
Methods
Perioperative management
Homogenization of perioperative management
Treatment of adverse reactions
Observation content
Evaluation criteria
Statistical methods
Results
General information
Group | Number | Age (years) | BMI (kg/m2) | ASA (II/III) | PSQI |
---|---|---|---|---|---|
Group A | 40 | 68.50 ± 2.93 | 21.79 ± 2.36 | 20/20 | 6.75 ± 1.96 |
Group B | 40 | 68.45 ± 2.82 | 21.76 ± 1.59 | 22/18 | 5.93 ± 2.29 |
Group C | 40 | 69.20 ± 3.01 | 22.45 ± 2.09 | 21/19 | 6.63 ± 2.38 |
F/x2 | - | 0.824 | 1.464 | 0.643 | 0.942 |
P | - | 0.441 | 0.236 | 0.725 | 0.393 |
Sleep quality score
Group | Number | Preoperative 1d | Postoperative 1d | Postoperative 3d | Postoperative 5d |
---|---|---|---|---|---|
Group A | 40 | 65.32 ± 8.01 | 59.68 ± 8.57 | 61.15 ± 7.79 | 66.95 ± 7.85 |
Group B | 40 | 64.77 ± 7.94 | 60.75 ± 7.33 | 63.83 ± 7.46 | 66.62 ± 8.63 |
Group C | 40 | 56.97 ± 7.51 | 51.58 ± 8.26 | 53.78 ± 8.67 | 58.97 ± 7.36 |
P | - | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |
Postoperative cognitive function measurement
Group | Number of cases | Preoperative 1d | Postoperative 1d | Postoperative 3d | Postoperative 5d |
---|---|---|---|---|---|
Group A | 40 | 26.45 ± 2.41 | 22.13 ± 2.54 | 23.58 ± 2.45 | 24.87 ± 2.45 |
Group B | 40 | 26.25 ± 2.52 | 24.63 ± 2.23 | 25.83 ± 2.53 | 26.15 ± 2.01 |
Group C | 40 | 27.13 ± 2.15 | 23.40 ± 2.68 | 24.65 ± 2.49 | 25.27 ± 2.69 |
p | - | 0.226 | < 0.0001 | < 0.0001 | < 0.0001 |
POD incidence
Group | Number of cases | Postoperative 1d | Postoperative 3d | Postoperative 5d |
---|---|---|---|---|
Group A | 40 | 3 (7.5) | 12 (30) | 15 (37.5) |
Group B | 40 | 1 (2.5) | 5 (12.5) | 5 (12.5) |
Group C | 40 | 4 (10) | 11 (27.5) | 13 (32.5) |
P | - | 0.348 | 0.135 | 0.036 |
Anxiety state assessment
Group | Number of cases | Preoperative 1d | Postoperative 1d | Postoperative 3d | Postoperative 5d |
---|---|---|---|---|---|
Group A | 40 | 8.30±2.07 | 7.80±2.04 | 5.65±1.73 | 5.40±1.55 |
Group B | 40 | 8.08±2.39 | 6.30±2.35 | 5.50±1.60 | 5.17±1.78 |
Group C | 40 | 8.30±2.24 | 8.13±2.46 | 6.93±1.86 | 7.18±2.29 |
F | - | 0.135 | 7.233 | 8.248 | 13.337 |
p | - | 0.874 | 0.001 | 0.000 | 0.000 |
Occurrence of adverse reactions and complications
Group | Number | Hypotension | Hypertension | Bradycardia | Lung infection | Postoperative bleeding | Total incidence |
---|---|---|---|---|---|---|---|
Group A | 40 | 4 (10.00) | 6(15.00) | 3 (7.50) | 1 (2.50) | 2 (5.00) | 16 (40.00) |
Group B | 40 | 1 (2.50) | 2(5.00) | 2 (5.0) | 1 (2.50) | 1 (2.50) | 7 (17.50) |
Group C | 40 | 3 (7.50) | 7(17.50) | 2 (5.00) | 2 (5.00) | 3 (7.50) | 17 (42.50) |
X2 | - | 6.825 | |||||
p | - | 0.033 |